Airbus, established in 1970, is a leading aerospace manufacturer known for its commercial aircraft, defense, and space products. With a diverse portfolio that includes the A320, A350, and A380 aircraft families, Airbus serves airlines worldwide, offering fuel-efficient and technologically advanced planes. Beyond commercial aviation, Airbus provides military transport, satellites, and launch vehicles, contributing significantly to global defense and space exploration. The company emphasizes innovation, sustainability, and safety, maintaining a strong presence across Europe, the Americas, and Asia.
Under the agreement, the partners will develop AI-driven solutions to predict radiotherapy system performance issues that could lead to delays in the management of patients treated at the Oncopole.
